Merck News, Merck Quote, MRK Quote

Merck (NY:MRK) Delayed: 128.66 +3.21 (2.56%)

Prev. Close

$125.45

Today 6M 1Y 5Y

Open

$125.83

52 Wk High

$65.46

52 Wk Low

$47.97

Day High

$128.78

Day Low

$125.83

P/E

87.52

EPS

$1.47

Volume

18,891,511

Friends, Peers and Foes (?): MKKGY, PFE, LLY, TERN, ABBV (more...)

ALERTS | RSS

Jun 25, 2026 06:45 AM FDA approves Merck's Keytruda combo with Trodelvy for TNBC
Jun 25, 2026 06:45 AM FDA Approves KEYTRUDA® (pembrolizumab) and KEYTRUDA QLEX™ (pembrolizumab and berahyaluronidase alfa-pmph), each with Trodelvy® (sacituzumab govitecan-hziy) as First-Line Treatment of PD-L1+ (CPS �
Jun 24, 2026 03:12 PM Form 11-K Merck & Co., Inc. For: Dec 31
Jun 24, 2026 03:09 PM Form 11-K Merck & Co., Inc. For: Dec 31
Jun 24, 2026 03:05 PM Form 11-K Merck & Co., Inc. For: Dec 31
Jun 24, 2026 08:30 AM The Quest to Repair What Multiple Sclerosis Takes Away
Jun 24, 2026 08:30 AM Next-Generation DNA Repair Inhibitors Could Capture Billions in Emerging Market
Jun 24, 2026 08:15 AM EMD Serono names new global commercial head and North America president
Jun 24, 2026 08:15 AM EMD Serono Announces Healthcare Leadership Changes for Global Commercial Strategy and North America
Jun 24, 2026 06:45 AM EU approves Merck's Keytruda plus Padcev for bladder cancer

Entities mentioned with MRK

View All Entities